Year: 2026
Type: editorial
Abstract: Uterine fibroids are the most common benign tumour of the female reproductive tract. For decades, surgery has been the standard treatment for symptomatic fibroids. However, minimally invasive options such as Uterine Artery Embolisation (UAE) have now emerged as a less invasive, but equally effective treatment. Despite this, access to UAE remains uneven worldwide. This cross-section from ten countries representing all inhabited continents across the globe, highlights several challenges that still exist, despite the abundance of evidence to support the long-term quality of life improvements for women treated with UAE. This narrative review considers enabling factors as well as barriers to treatment in each region, putting forward local strategies to improve access to UAE moving forward.
Source: CVIR Endovascular
Institutions: Complejo Hospitalario Universitario de Ferrol, University of Geneva, University of Bern, University Hospital of Geneva, Cork University Hospital, University of California, Los Angeles, Aston University, Hamad Medical Corporation, University Hospitals of the Ruhr-University of Bochum, St. Josef-Hospital, Ruhr University Bochum, Universidade Federal de São Paulo, The Alfred Hospital, National Trauma Research Institute, Monash University
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,590
OpenAlex ID: W7142341779